In the US, Zinacef (cefuroxime systemic) is a member of the drug class second generation cephalosporins and is used to treat Bacterial Infection, Bladder Infection, Bone infection, Bronchitis, Epiglottitis, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Impetigo, Joint Infection, Kidney Infections, Lyme Disease, Meningitis, Otitis Media, Peritonitis, Pneumonia, Sepsis, Sinusitis, Skin and Structure Infection, Skin Infection, Strep Throat, Surgical Prophylaxis, Tonsillitis/Pharyngitis, Upper Respiratory Tract Infection and Urinary Tract Infection.
Ingredient matches for Zinacef
Cefuroxime is reported as an ingredient of Zinacef in the following countries:
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Zinacef in the following countries:
Cefuroxime sodium (a derivative of Cefuroxime) is reported as an ingredient of Zinacef in the following countries:
- Bosnia & Herzegowina
- Czech Republic
- Hong Kong
- New Zealand
- Russian Federation
- South Africa
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.